CD274 and neoplasm: Clinicians can measure the expression level of PD-L1 in tumor cells and immune cells examined by diverse techniques i.e. immunohistochemistry and in situ hybridization, and in whole tissue specimens measured by real-time PCR to provide important predicating information of response prior treatments.